CCL2 and alcoholic liver diseases: These previous findings indicate that LAB treatment inhibits the production of IL-6, IL-12, and MCP-1, as well as the accumulation of lipid droplets that cause alcoholic liver damage, suggesting they could play a role in alleviating ALD.